PLCB1 and glioblastoma: Recent findings highlighted an effective role of PLCβ1 in supporting a less aggressive phenotype of the tumor, demonstrating that its gene was relatively less expressed in glioblastoma patients compared to in their healthy/low-grade counterparts [36].